A fat embolism (which via major trauma may progress to fat embolism syndrome) is a type of embolism in which the embolus consists of fatty material. They are often caused by physical trauma such as fracture, soft tissue trauma, or burns. Fat embolism syndrome is distinct from the presence of fat emboli, symptoms usually occur 1–3 days after a traumatic injury and are predominantly pulmonary (shortness of breath, hypoxemia), neurological (agitation, delirium, or coma), dermatological (petechial rash), and haematological (anaemia, low platelets). The syndrome manifests more frequently in closed fractures of the pelvis or long bones.
|Haematoxylin and eosin stain of a microscopic section of the lungs showing a blood vessel with fibrinoid material and an optical empty space indicative of the presence of lipid dissolved during the staining process.|
|Diagnostic method||Doppler ultrasonography, TEE|
Clinical manifestation of fat embolism syndrome (FES) can start from 12 hours to 3 days after diagnosis of the underlying clinical disease. The three most characteristic features are: respiratory distress, neurological features, and skin petechiae. Respiratory distress (present in 75% of the cases) can vary from mild distress which requires supplemental oxygen to severe distress which requires mechanical ventilation. For neurologic features, those who have FES may become lethargic, restless, with a drop in glasgow coma scale (GCS) due to cerebral oedema rather than cerebral ischaemia. Therefore, neurological signs are not lateralised to one side of the body. In the severe form of cerebral odema, a person may become unresponsive. Petechiae rash usually happens in 50% of the patients. Such skin manifestation is temporary and can disappear within one day. The fat embolism syndrome can be divided into three types:
- Subclinical FES - It manifests as reduced partial pressure of oxygen (PaO2) on arterial blood gas (ABG) with deranged blood parameters (reduced haemoglobin or thrombocytopenia) associated with fever, pain, discomfort, tachypnoea, tachycardia. However, there is no respiratory distress. However, it is often confused with post-operative symptoms of fever, pain, and discomfort.
- Subacute FES (non-fulminant FES) - The three characteristic features of fat embolism are present: respiratory distress, neurological signs, and skin petechiae. Petechiae are seen on the chest, axilla, shoulder, and mouth. Occulsion of dermal capillaries by the fat emboli resulted in petechial rash. Petechiae rash occurs in 50 to 60% of the cases. Neurologic signs such as confusion, stupor, and coma maybe present. These are usually temporary and does not happen on one side of the body. Respiratory distress can be mild and tend to improve on the third day. Retinal changes similar to Purtscher's retinopathy may also be present. Retinal changes happens in 50% of the patients with FES. These are the cotton wool exudates and small haemorrhages along the retinal vessels and macula.
- Fulminant FES - This type of FES is much rarer than the above two types. It usually happens within the first few hours of the injury. The three characteristics of FES existed in the most severe form. Cause of death is usually due to acute right heart failure.
Orthopaedic injuries especially fractures of the long bones are the most common cause of fat embolism syndrome (FES). The rates of fat embolism in long bone fractures varies from 1% to 30%. The mortality rate of fat-embolism syndrome is approximately 10–20%. However, fat globules have been detected in 67% of those with orthopaedic trauma and can reach as high as 95% if the blood is sampled near the fracture site. As the early operative fixation of long bone fractures become a common practice, the incidence of FES has been reduced to 0.9% to 11%.
Other rare causes of fat embolism syndrome are:
- severe burns
- liver injury
- closed chest cardiac massage (during cardiopulmonary resuscitation)
- bone marrow transplanatation
- parental lipid infusion
- decompression sickness
- extracorporeal circulation
- acute haemorrhagic pancreatitis
- alcoholic liver disease
- prolonged corticosteriod therapy
- sickle cell disease
- carbon tetrachloride poisoning
Once fat particles enter the blood circulation, it can lodge at various sites of the body, most commonly in the lungs (up to 75% of the cases). However, it can also enter the brain, skin, eyes, kidneys, liver, and heart circulation, causing capillary damage, and subsequently organ damage in these areas. There are two theories that describes the formation of a fat embolus:
- Mechanical theory - Following trauma, fat is released directly from the bone marrow into the circulation. This is because after trauma, an elevated pressure in the medullary cavity (central cavity of the bone where the bone marrow are stored) of the bone causes the release of fat globules into venous system supplying the bone. This explains the obstruction of the fat emboli in the lung capillaries. However, it does not explain the fat embolism in other parts of the body (brain, skin, heart, and eyes) because the small diameters of lung capillaries does not allow the fat emboli to pass through lung circulation back into the left ventricle of the heart to be pumped throughout the body. For those without a patent foramen ovale (a hole communicating the right atrium directly to the left atrium of the heart), fat emboli still can be found in other parts of the body apart from the lungs. If fat globules obstructs 80% of the lung capillary network, it will cause acute right heart failure which resulted in death. Obstruction of fat globules in the lung capillaries can cause an increase in lung capillary pressures. This increase in pressure causes lung to be more stiff, and increases the workload of the right heart. The back pressure on the right heart causes right heart dilatation through cor pulmonale which causes acute right heart failure.
- Biochemical theory - Following trauma, an inflammation causes bone marrow to liberate fatty acids into the venous circulation. This is achieved through the increased activity of lipoprotein lipase which break down triglycerides into free fatty acids. Both the release of fatty acids and the inflammation causes damage to the capillary beds of the lungs and other organs, causing interstitial lung disease, chemical pneumonitis, and acute respiratory distress syndrome (ARDS). This theory can help to explain non-traumatic causes of fat embolism.
Fat embolism is presence of fat particles in the micro-circulation of the body. Meanwhile, fat embolism syndrome is the clinical manifestation as the result of fat particles lodging in the body micro-circulation. There are three major diagnostic criteria proposed for fat embolism syndrome, however, none of them are validated and accepted universally. However, Gurd and Wilson's criteria for fat embolism become more commonly used when compared to the other two diagnostic criteria.
Gurd and Wilson's criteria for fat embolism syndromeEdit
- Axillary or subconjunctival petechiae
- Hypoxaemia PaO2 <60 mm Hg, FIO2 = 0.4
- Central nervous system depression disproportionate to hypoxaemia
- Pulmonary oedema
- Tachycardia more than 110 beats per minute
- Pyrexia more than 38.5 °C
- Fat globules present in urine
- Changes in renal function (reduced urine output)
- Drop in haemoglobin values (more than 20% of the value upon admission)
- Drop in haematocrit values
- Drop in platelet values (more than 50% of the value upon admission)
- Increasing erythrocyte sedimentation rate (ESR) (greater than 71 mm per hour)
- Fat globules present in the sputum
- Emboli present in the retina on fundoscopy
A least two positive major criteria plus one minor criteria or four positive minor criteria are suggestive of fat embolism syndrome. Fat embolism syndrome is a clinical diagnosis. There are no laboratory tests sensitive or specific enough to diagnose FES. Such laboratory tests are only used to support the clinical diagnosis only. Chest X ray may show diffuse interstitial infiltrates while chest CT scan will show diffuse vascular congestion and pulmonary oedema. Bronchoalveolar lavage has been proposed to look for fat droplets in alveolar macrophages however it is time consuming and is not specific to fat embolism syndrome. Looking for fat globules in sputum and urine is also not specific enough to diagnose FES.
For those treated conservatively with immobilisation of long bone fractures, the incidence of FES is 22%. Early operative fixation of long bone fractures can reduce the incidence of FES especially with the usage of internal fixation devices. Patients undergoing urgent fixation of long bone fractures has a rate of 7% of acute respiratory distress syndrome (ARDS) when compared to those undergoing fixation after 24 hours (39% with ARDS). However, movement of the fracture ends of the long bones during the operative fixation can cause transient increase of fat emboli in the blood circulation. Cytokines are persistently elevated if the long bone fractures is treated conservatively using immobilisation. The cytokine levels would return to normal after operative fixation. Although ream nailing increases pressure in the medullary cavity of the long bones, it does not increase the rates of FES. Other methods such as drilling of holes in the bony cortex, lavaging bone marrow prior to fixation, and the use of tourniquets to prevent embolisation have not been shown to reduce the rates of FES.
Corticosteroid therapy such as methylprednisolone (6 to 90 mg/kg) has been proposed for the treatment of FES, however it is controversial. Corticosteroid can be used to limit free fatty acid levels, stabilising membranes, and inhibit leukocyte aggregation. A meta-analysis conducted in 2009 reported prophylactic corticosteroids can reduce the risk of FES by 77%. However, there is no difference in mortality, infection, and avascular necrosis when compared to the control group. However, a randomised trial conducted in 2004 reported no differences in FES incidence when comparing treatment with the control group. Administration of corticosteriods for 2 to 3 days is not associated with increased rates of infection. However, there is insufficient data to support the use of methyprednisolone once FES is established.
Heparin has been used in the prevention of venous thrombosis in post-operative patients; however its regular use in those with FES has been contraindicated due to increase risk of bleeding in those suffering from polytrauma.
Once FES develops, the person should be admitted into intensive care unit (ICU), preferably with central venous pressure (CVP) monitoring. CVP monitoring would be helpful to guide the volume resuscitation. Supportive treatment is the only proven treatment method. Supplemental oxygen can be given if a person has mild respiratory distress. However, if a person has severe respiratory distress, either continuous positive pressure ventilation (CPAP), or mechanical ventilation using positive end-expiratory pressure (PEEP) may be indicated. Fluid replacement is required to prevent shock. Volume resuscitation with human albumin is recommended because it can restore blood volume in the circulatory system while also binds to free fatty acids in order to reduce lung injuries. In severe cases, dobutamine should be used to support the right ventricular failure. Frequent Glasgow coma scale (GCS) charting is required access the neurological progression of a person with FES. A placement of intracranial pressure monitor may be helpful to direct the treatment of cerebral odema.
In 1861, Zenker first reported on the autopsy findings of fat droplets found in the lungs of a railway worker who died due to severe thoracoabdominal crush injury. In 1873, Bergmann diagnosed fat embolism clinically in a patient with fractured femur. In 1970, Gurd defined the characteristics of this phenomenon. Gurd later modified the fat embolism criteria together with Wilson, thus producing Gurd and Wilson's criteria for fat embolism syndrome in 1974. In 1983, Schonfeld suggested a scoring system for the diagnosis of fat embolism syndrome. In 1987, Lindeque proposed another scoring system that diagnose fat embolism syndrome by using respiratory changes alone. However, none of them become universally accepted in the medical community.
- Laurence, Knott (19 February 2014). "Fat embolism syndrome". patient.info. Retrieved 14 March 2018.
- "Fat Embolism Clinical Presentation: History, Physical Examination". emedicine.medscape.com. Retrieved 2017-11-26.
- George, Jacob; George, Reeba; Dixit, R.; Gupta, R. C.; Gupta, N. (2013). "Fat embolism syndrome". Lung India : Official Organ of Indian Chest Society. 30 (1): 47–53. doi:10.4103/0970-2113.106133. ISSN 0970-2113. PMC 3644833. PMID 23661916.
- Michael E, Kwiatt; Mark J, Seamon (March 2013). "Fat embolism syndrome". International Journal of Critical Illness and Injury Scienc. 3 (1): 64–68. doi:10.4103/2229-5151.109426. PMC 3665122. PMID 23724388.
- Korhan, Taviloglu; Hakan, Yanar (1 January 2007). "Fat embolism syndrome". Surgery Today. 37 (1): 5–8. doi:10.1007/s00595-006-3307-5. PMID 17186337.
- Saigal, R; Mittal, M; Kansai, A; Singh, Y; Kolar, PR; Jain, S (April 2008). "Fat embolism syndrome" (PDF). Journal of the Association of Physicians of India. 56 (392): 245–249. PMID 18702388. Retrieved 14 March 2018.
Diagnosis is usually made on the basis of clinical findings but biochemical changes may be of value. The most commonly used set of major and minor diagnostic criteria are those published by Gurd (See Table 2 ).
- Shaikh, Nissar (2009). "Emergency management of fat embolism syndrome". Journal of Emergencies, Trauma, and Shock. 2 (1): 29–33. doi:10.4103/0974-2700.44680. ISSN 0974-2700. PMC 2700578. PMID 19561953.
- Silva, Douglas Fini; Carmona, César Vanderlei; Calderan, Thiago Rodrigues Araújo; Fraga, Gustavo Pereira; Nascimento, Bartolomeu; Rizoli, Sandro (2013). "The use of corticosteroid for the prophylaxis of fat embolism syndrome in patients with long bone fracture". Revista do Colegio Brasileiro de Cirurgioes. 40 (5): 423–426. ISSN 1809-4546. PMID 24573593.
- Lewis, Sharon L.; Dirksen, Shannon Ruff; Heitkemper, Margaret M.; Bucher, Linda (2013-12-02). Medical-Surgical Nursing: Assessment and Management of Clinical Problems, Single Volume. Elsevier Health Sciences. p. 1523. ISBN 9780323086783.
- Nolan, Jerry; Soar, Jasmeet (2012-06-28). Anaesthesia for Emergency Care. OUP Oxford. p. 86. ISBN 9780199588978.
- Bederman SS, Bhandari M, McKee MD, Schemitsch EH (2009). "Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis". Can J Surg. 52 (5): 386–93. PMC 2769117. PMID 19865573. .
- Dondelinger, Robert F. (2004). Imaging and Intervention in Abdominal Trauma. Springer Science & Business Media. p. 477. ISBN 9783540652120.
- George, Ronald B. (2005-01-01). Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. Lippincott Williams & Wilkins. p. 222. ISBN 9780781752732.
- Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Mitchell, Richard (2007-05-24). Robbins Basic Pathology. Elsevier Health Sciences. p. 505. ISBN 1437700667.